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[ Abstra~l J 
This study sought o identify, by means of several analytical 
methods (GC-MS, HPLC-DAD, CE-DAD, FTIR, and NMR), 
4-bromo-2,5-dimethoxyphenethylamine (2C-B), which was 
found in two sets of tablets obtained from the Swiss black 
market. Unequivocal identification of 2C-B was only achieved 
by a combination of mass spectrometric and NMR analysis. 
Quantitation of 2C-B was performed by HPLC-DAD and 
CE-DAD. The amounts of 2C-B found in the tablets (3--8 mg) 
were in the range of the minimum quantity required to induce 
the effects characteristic of this drug. 
Introduction 
4-Bromo-2,5-dimethoxyphenylethylamine (2C-B, Figure 1) is 
a psychoactive drug related to mescaline (3,4,5-trimeth- 
oxyphenylethylamine) and other structurally similar drugs 
such as 4-methyl-2,5-dimethoxyamphetamine and 4-bromo- 
2,5-dimethoxyamphetamine. All of these drugs possess signif- 
icant abuse potential (1). 
2C-B, also known under a variety of street names uch as 
"Venus", "Bromo", "Erox", and "Nexus", should be considered 
as an illegal substance with regard to the Swiss law on narcotic 
substances. Only scarce data exist about its pharmacological 
properties, metabolism, and toxicity (1-4). Because of its very 
low cross-reactivity, 2C-B is hardly detectable in urine with 
commercially available immunoassays (5,6), and nothing is 
known about its use and involvement in morbidity, mortality, 
and car accidents. Moreover, very little data exist about the
composition of 2C-B tablets. 
In humans, 2C-B is active at doses between 4 and 30 rag. 
Within this range, the ingestion of 2C-B induces considerable 
euphoria with an increased receptiveness of thevisual, auditory, 
olfactory, and tactile sensations. These eff cts are very likely me- 
diated because of the affinity of central serotonin receptors (1). 
Higher doses may cause frightening hallucinations and unex- 
pected heavy trips, and it is impossible for the consumer to 
know the exact content of a "street" tablet. The duration of ac- 
tion is between 4 and 8 h (7,8). 
2C-B is frequently combined with Ecstasy and other elated 
compounds or taken together with ketamine. It is difficult to 
determine if 2C-B and ketamine are taken simultaneously or
separately during the same psychedelic trip, and theformal 
identification of 2C-B is difficult because many related com- 
pounds and isomers can be found on the black market (7,9). For 
instance, all possible isomeric dimethoxybenzaldehydes (2,3-, 
2,4-, 2,5-, 2,6-, 3,4-, and 3,5-) are commercially available (e.g., 
from Fluka nd Aldrich) and can be used as precursors for the 
synthesis of 2C-B and of its positional isomers. DeRuiter et al. 
(10) showed that the mass spectra of some of the isomeric 
bromo-dimethoxyphenylethylamines differ only in the re ative 
abundance of some high mass fragment clusters. Therefore, 
mass spectrometry alone does not allow full identification of the 
substitution pattern (11). 
Here, we report on the composition of two kinds of street 
tablets sold in the French part of Switzerland as Ec tasy in 
which 2C-B was detected as one of the main psychoactive com- 
pounds. 2C-B was Unequivocally identified by means of several 
analytical tools such as infrared (IR) and ultraviolet (IN) spec- 
troscopy, mass spectrometry (MS), and nuclear magnetic reso- 
nance (NMR) spectroscopy. 
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Material and Methods 
Case histoff 
Case 1 (sampleA). The 2C-B tablets were seized by the police 
together with other pills containing amphetamine or
methylenedioxymethamphetamine and/or various Ecstasy 
analogues, methylenedioxyamphetamine, N-m thyl-l-(3,4- 
methylenedioxyphenyl)-2-butanamine (MBDB), and methylene- 
dioxyethylamphetamine (MDEA). The tablets were round, 1-cm 
wide and 3-mm thick, white, with a dollar logo on one side and 
a small step scored on the reverse side, and weighed about 320 
mg each (Figure 2). 
Case 2 (sample B). The 2C-B tablets were very likely seized 
before the dealer could sell them on the street. They were pur- 
chased abroad along withseveral "smart drugs". The pills were 
round, 0.5-cm wide and 2-ram thick, white, stepped on both 
sides, not scored, and weighed about 50 mg each (Figure 2). 
Chemicals and standards 
2C-B and MBDB standards were obtained as hydrochlorides 
through Research Biochemicals International (RBI | Natick, 
MA). The internal standard (2-phenylethylamine) used for th  
capillary electrophoresis (CE) quantitation was purchased from 
Fluka (Buchs, Switzerland). The seized tablets were collected by
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the Institute of Legal Medicine of the University of Lausanne. 
Ultrapure water was provided by a Milli-Q RG unit from Milli- 
pore (Bedford, MA). Deuterated water (D~O: 99.95 atom%D) 
used as solvent for NMR experiments was provided by Aldrich 
(Buchs, Switzerland). All other reagents, solvents, and sub- 
stances were analytical-grade reagents from Fluka. 
Sample preparation 
Gas chromatography-mass spectrometry (GC-MS) and 
high-performance liquid chromatography-diode-array detect- 
ion (HPLC-DAD). The tablets were crushed with a mortar and 
pestle before preparing a methanolic stock solution (10 mL) at 
1 mg powder/mL. For GC-MS, samples were analyzed either 
underivatized orafter acetylation r methylation. The acetyl- 
at.ion process was performed as follows: one drop of an ethanolic 
solution of 1% HCl was added to 100 laL of the methanolic 
stock solution f the exhibit. After this, the sample was taken to 
dryness under a stream of nitrogen and acetylated at 60~ 
during 30 min with 100 pL of a mixture of acetic anhydride and 
pyridine (3:2, v/v). After evaporation of the reagent and addition 
of 100 pL of ethyl acetate to the residue, 1 pL was injected into 
the GC-MS. Methylation was performed as follows: 50 mg an- 
hydrous potassium carbonate, 180 pL acetonitrile, and 20.1aL 
iodomethane were added to the dry residue; after methylation 
H3CO ~ , I ~  NH2 
H 3 CO " ~  
OCH 3 
Mescaline 
OCH 3 
H3CO T 
Br 
5 -Bromo-2,4 -dimethoxyphenylethylamine 
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Figure |. Chemical structures of 2C-B and related compounds. Abbreviations: 2C-B, 4-bromo-2,5-dimethoxyphenylethylamine; escaline, 3,4,5- 
trimethoxyphenylethylamine; DOM, 4-methyl-2,5-dimethoxyamphetamine; nd DOB, 4-bromo-2,5-dimethoxyamphetamine. 
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Figure 2. Photographs of the two sets of seized tablets (sample A with $ imprint). Dimensions are 
in millimeters. 
over 3 h at 60~ 1 pL was injected into the GC-MS. 
CE. Before analysis, each tablet was weighed and pulverized 
into a fine and homogeneous powder. We prepared two stock 
solutions by dissolving approximately 10 mg of each tablet in 
10 mL of 0.1M HCi (sample A). For sample B, only one stock so- 
lution was prepared bydissolving approximately 3 mg of each 
tablet in 10 mL of 0.1M HCI, in order to keep sufficient mate- 
rial for further NMR studies. The solutions were sonicated for 
30 rain to facilitate the solubilization, then vortex mixed and fil- 
tered through 0.45-pro nylon Titan syringe filters (Scientific Re- 
sources Inc., Eatontown, N J). The internal standard was added 
during the final dilution step of the previously mentioned fil- 
tered solutions i  order to reach a concentration f 10 mg/mL. 
Liquid-liquid extraction. Before the investigation by NMR 
and IR, the tablets containing only 2C-B (sample B) were indi- 
vidually ground with a mortar and pestle to a fine and homo- 
geneous powder. Aliquots were withdrawn for quantitation. 
The remaining crushed tablets were gathered, and the whole lot 
was dissolved in 3 mL of 0.1M HCl. The solution was sonicated 
for 30 rain. Two-hundred microliters of NH4OH (25%) and 6 
mL of methylene chloride (HPLC grade) were added. 
The solution was mixed for 1 rain in a vortex mixer and 20 
rain in a rotative mixer. After centrifugation for 6 rain at 4000 
rpm (approximately 1750 x g) and after freezing the aqueous 
phase at-20~ the organic phase was collected. For acidifica- 
tion, 200 pL of a solution of HCl/isopropanol (1:4, v/v) were 
added. The organic solvent was evaporated to dryness under ni- 
trogen, and the residue was used for IR and NMR investigations. 
Equipment 
GC-MS. The samples were analyzed with a Hewlett-Packard 
(HP) 5890 GC fitted with an HP 7673A automatic liquid sampler 
and equipped with a quadrupole HP 5971 mass elective de- 
tector. Electron-impact full mass spectra were obtained at an 
ionization voltage of 70 eV. The analytes were separated with a
HP Ultra-2 capillary column (fused silica coated with 5% 
phenylmethylsilicone phase, 25 m x 0.2-ram i.d., 0.33-pm film 
thickness). Helium was used as the carrier gas, 
and the column head pressure was set at 15 psi. 
One microliter of each of the samples was in- 
jected using the splitless mode with a purge 
time of 1 rain. The injection port and the 
transfer line were set at 260 and 290~ respec- 
tively. The electron multiplier was set at 150 V 
above the tune value. Full-scan mass spectra 
were collected at a rate of 1 scan/s between 50 
and 450 ainu. The oven temperature was pro- 
grained from 55~ (initial time of I rain) to 
190~ at a rate of 20~ then heated to 
305~ at 10~ The final temperature was 
maintained during 11 rain (total run time of 
approximately 30 rain). Data acquisition and 
analysis were performed with an HP Vectra XM 
series 4 5/150 ChemStation using Windows 95 
operating software. Data were automatically 
processed with so-called "macro" programs, 
using the Pfleger et al. (13), Wiley, and Amer- 
ican Academy of Forensic Sciences (AAFS) ref- 
erence mass spectra libraries and our own databases for 
tentative mass spectra identification of phenylethylamines. 
Further unequivocal identification was generally performed by 
comparing spectra of the unknown with reference spectra of 
genuine samples obtained under the same conditions. 
HPLC-DAD. The quantitation f phenylethylamines was per- 
formed by reversed-phase HPLC on a Hewlett-Packard HP 1090 
LC interconnected with an HP DAD. Fifty microliters of a 
ephedrine solution (1 mg/mL in methanol) was added to 100 pL 
of stock solution of powder (1 mg/mL in methanol) that was di- 
luted with the starting HPLC eluent o 100 pg/mL. Twenty-five 
microliters of this solution was loaded onto a short enrich- 
ment precolumn (Lichrospher RP-8 Select B, 75 mmx 4-ram 
i.d., 5-pro particle size, Merck, Darmstadt, Germany) over 1.7 
rain at a flow rate of 0.5 mL/min. The initial mobile phase 
composition was 5% acetonitrile in 10raM potassium phos- 
phate buffer (pH 3.2). After washing off the salts, sugars, and 
other impurities, the flow was reversed and then increased to 1 
mL/min. The separation of the analytes took place at 40~ on a 
25 cm-long Lichrospher RP-8 Select B column (4-ram i.d., 5- 
pm particle size). The proportion of acetonitrile in the eluent 
was increased during run from 5 to 60% in 20 rain. The eluent 
was monitored at 210 nm with a window of 44 nm, and full 
spectra were recorded between 210 and 400 nm. Each column 
was protected by a Merck RP-8 guard column (4 mm x 4-pro 
i.d., 5-pro particle size). Thecalibration curve was obtained 
with standard solutions f 2C-B at 1, 2, 5, 10, 25, 50, 75, and 100 
pg/mL. Each concentration was prepared in duplicate. Standard 
calibration curves were obtained from unweighted, least 
squares linear regression analysis of the data. The linearity of 
the method was statistically tested. 
CE. A Hewlett-Packard Hp3DCE system was used for the ana- 
lyses. This system consisted of a CE unit equipped with a DAD, 
an autosampler, and a high-velocity air-cooled capillary car- 
tridge. The Hp3DCE ChemStation software was used for in- 
strument control, data acquisition, and data analysis. The 
capillary was offused silica with a 56-cm effective l ngth and a 
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64.5-cm total length with an inner diameter of 50 pm (375-pm 
o.d.). Between ach run, the capillary was flushed with the 
electrophoretic buffer for 3 rain. Samples (approximately 25 nL) 
were injected by a positive pressure (1000 mbar.s), and dec- 
trophoresis was performed ata constant voltage of 20 kV (ap- 
proximately 310 V/cm) after a l-rain ramp step. All runs were 
carried out at 20~ • 0.1~ (cassette temperature) with a 50raM 
Tris-phosphate buffer (pH 2.5). Pherograms were monitored at 
200 nm (20 nm bandwidth) and a reference signal at 350 nm 
(100 nm bandwidth). Areas were always corrected by their re- 
spective migration time (MT) (12). The calibration curve was 
performed with standard solutions f 2C-B at 0.5, 0.75, 1, 5, 10, 
and 15 pg/mL. Each concentration was prepared in duplicate. 
A standard calibration curve was obtained from unweighted 
least squares linear regression analysis of the data. The lin- 
earity of the method was statistically tested. 
Fourier-transform infrared spectroscopy (FTIR). The IR spec- 
troscopy was performed on the residue resulting from 
liquid-liquid extraction (approximately 2%, w/w) with a 
PARAGON 500 FTIR (Perkin Elmer, Norwalk, CT) with four 
scans (16 s) from 4000 to 500 cm -1 on a KBr dispersion disk. 
NMR. The 1H-NMR and 13C-NMR spectra and the nuclear 
overhauser xchange spectroscopy (NOESY) experiments were 
performed on a Bruker AMX 400 MHz. The gs-heteronuclear 
multiple quantum coherence (HMBC) experiment was per- 
formed on a Bruker AMX-2 600 MHz. The residue resulting 
from liquid-liquid extraction and the reference 2C-B were dis- 
solved in deuterated water (DzO: 99.95 atom%D) at a concen- 
tration of approximately 1.5 mg/mL. 
Results and Discussion 
Qualitative results 
GC-MS. Besides 2C-B, the routine drug screenings per- 
formed by GC-MS on the two exhibits revealed the presence of 
MBDB in sample A and sugars in both samples (Table I). The 
search for precursors and synthesis impurities remained un- 
successful, suggesting that the psychoactive drugs were care- 
fully purified before b ing used for making the pills. To our 
knowledge, it is the first report of the presence of 2C-B in illicit 
tablets sold inSwitzerland. Because many related compounds 
with similar mass pectra may exist as street drugs, 2C-B was 
only tentatively identified w th our routine GC-MS procedures. 
The mass pectra of the unknown and of an authentical stan- 
dard from RBI are shown in Figures 3-6. All mass spectra, un- 
derivatized (Figure 3), acetylated (Figure 4), methylated (Figure 
5), or of the formyl artifact (Figure 6), of the unknown (see 
Table I. Chemical Composition of the Two Sets of Illicit Tablets 
Sample Weight* Phenylethylamines 2C-B Others 
A 320 mg MBDB, 2C-B 5-8 mg lactose 
B 50 mg 2C-B 3-5 mg galactose, glucose, and lactose 
9 Approximate weight. 
upper parts of the corresponding figures) are almost identical 
to the reference spectra (lower parts of the figures). The molec- 
ular ion (m/z 259/261) (Figure 3) and the fragment ions con- 
taining one bromine atom were easily identified when based on 
the nearly equal isotopic ratios of 79Br and 81Br (e.g., 201/203, 
215/217, 230/232). 
The putative structures ofthe main fragments are shown in 
the lower part of Figure 3. Two families of fragments were rec- 
ognized. The first corresponded to the bromodimethoxy-sub- 
stituted benzenic ion with a missing part ofthe partial (m/z 
230/232) or entire ethylamine side chain (m/z 215/217). When 
the spectrum was scanned between 50 and 450 ainu, the ion 
fragments at m/z 230/232 constituted the base peak; other- 
wise, it was the ion at m/z 30 that was the base peak (results not 
shown). The second ion family was constituted by the unsub- 
stituted aromatic ring (ra/z 77), toluene (m/z 91), phenylethyl 
(m/z 105), and phenylethylamine (m/z 121) fragments. The 
ion pair at m/z 199 and 201 could result from the loss of CH~O 
from the ion fragments at m/z 230 and 232. No fragment that 
was due to the loss of the bromine atom (m/z 79 and 81) from 
the molecular ions (m/z 259 and 261) was detected in a signif- 
icant amount at m/z 180. 
The spectra ofthe unknown acetylated and of the acetylated 
2C-B standard are shown in Figure 4. They are almost identical. 
The base peak (m/z 242/244) very likely arose from the loss of 
the acetylated amine moiety. Loss of the acetylated methyl- 
amine side chain (m/z 72) should result in the pair of fragments 
at m/z 229 and 231. The loss of bromine from the ion cluster at 
m/z 227 and 229 might result in the prominent fragment at m/z 
148. No molecular ion could be found following methylation f 
2C-B with iodomethane (Figure 5). Otherwise, the mass spectra 
of the acetylated and of the methylated molecules were very 
similar with some differences in the relative intensities of the 
ion fragments. The aviest ion duster at m/z 242 and 244 
very likely resulted from the loss of the dimethylamine moiety. 
Figure 6 displays the formyl artifact of 2C-B (M § m/z 271/273), 
which was probably formed in the injection port of the GC by 
reaction with formaldehyde and subsequent dehydration (13). 
The mass spectrum of the unknown (Figure 6, upper part) is 
very similar to that of the formyl artifact of 2C-B found in the 
Pfleger et al. (13) database (Figure 6, lower part). 
The position of the bromine atom relative to the methoxy 
groups could not be determined from these comparisons. There- 
fore, the results shown here indicated that the tablets 
contained 2C-B or one of its isomeric analogues. The three ortho 
brominated positional isomers of the bromodimethoxyphenyl- 
ethylamines (Figure 1, compounds G-I) were all characterized by 
a (M-Br) § ion at m/z 180 (9), which was lacking in our spectrum. 
Thus, in the light of these GC-MS experiments, i  could only 
be concluded that he bromodimethoxyphenyl- 
ethylamine detected in the seized tablets was 
bromo-substituted in position meta or para with 
regard to the ethy]amine side chain (Figure 1, 
compounds D-F). 
FTIR spectroscopy. The IR spectra of the ref- 
erence and of the analyte presumed to be 2C-B 
were almost identical. A typical spectrum is 
shown in Figure 7. The most characteristic bands 
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are the broad ammonium band due to -NHa + at 3040 cm -1, Vst (C- 
H aromatic) and vst (C-H aliphatic) 3050-2850 cm -1, vst (OCH3) 
at 1250 cm -z, and vst (C-Br) at 740 cm -z. Furthermore the iso- 
lated aromatic H gave two sharp weak bands at 825 and 750 
cm-l. 
UV-visible spectroscopy. UV spectra of the reference and of 
the phenylethylamine presumed to be 2C-B were recorded by 
HPLC-DAD and CE--DAD. Both spectra were identical and show 
a maximum absorbance at 293 nm and a shoulder between 
215 and 230 nm (Figure 8). Caffeine, which is a common 
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adulterant in Ecstasy tablets, is also shown on the same figure. 
NMR spectroscopy. NMR is a powerful tool in structural de- 
termination but has rarely been used in forensic analysis. NMR 
makes it possible to study the chemical environment of many 
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nuclei, hydrogen and carbon in particular. 
One (1D), two (2D), or even more dimensions maybe used 
for experiments. Higher dimensions are used when lower 
dimensions cannot be interpreted without ambiguity. 
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Furthermore, many different types of experiments, which de- 
pend on what is looked for, exist. For example, the connec- 
tivity through bonds or scalar coupling between various 
hydrogens i  given by ZH-NMR or correlation spectroscopy 
(COSY) experiments; or else the connectivity through space or 
dipolar coupling by NOE (nuclear overauser effect) or NOESY 
experiments; or the direct or long-range bonding between 
hydrogen and carbon by 2D heteronuclear experiments. 
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The chemical shifts of the different signals obtained for the 
1H-NMR and ~3C-NMR spectra of the compound under study, at 
400 MHz and 100 MHz, respectively, are s follows: ]H-NMR 
(400 MHz, D20) ~ (ppm): 7.17 (s, H-C3), 6.88 (s, H-C6), 3.71 
(s, MeO-C5), 3.08 (s, MeO-C2), 3.08 (t, 3J=7 Hz, CH2N), 2.84 
(t, 3J=7Hz, CH2) and ]3C-NMR (100 MHz, D20) ~ (ppm): 154.9 
(C~), 152.13 (C5), 128.11 (C]) 119.33 (C3), 118.47 (C6), 112.46 
(C4), 52.73 (MeO-Cs), 42.15 (MeO-C2), 42.15 (CH2N), 30.53 
(CH2). 
The 1H-NMR spectra, in D20 shows two aromatic protons 
(7.17, 3.88 ppm) in apara substitution, since th y have no fine 
structures. There ar  also two methoxy groups (3.71, 3.68 
ppm) and a CH2CH2N group. Furthermore, the]H-NMR and 
the ]3C-NMR show the presence of ethylene glycol at 3.5 ppm 
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Figure 6. Mass spectra of the unknown (upper part) and of the reference spectrum of the formyl artifact of 2C-B (lower part) from the Pfleger et al. (13) library 
spectra database. 
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and 65.33 ppm, respectively. Both spectra permitted to rec- 
ognize the different functional groups contained in the bro- 
rnodimethoxyphenylethylamine isom rs. These conclusions 
lead us to propose the structures ofcompounds D,E, and I in 
Figure 1 for the suspected 2C-B molecule found in the tablet. 
Another NMR experiment, NOESY, was also performed on 
IR spectrum of 2C-B tablet A 
I I I I I I 
4000 3000 1500 1000 51)0 2000 
r  -I 
IR spectrum of 2C-B standard B 
i i i I i i 
4000 3000 2000 1500 I000 $00 
r  
Figure 7. IR spectra of the unknown (A) and of the 2C-B standard (B). 
our compound, and it allowed the connection through space 
and not through bonds. In this case, there were two possible 
structures that were compatible with the NMR data (com- 
pounds E and I in Figure 1) because both have a methoxy 
group near one of the two aromatic proton. Therefore, the 
compound I structure can be neglected with reference to our 
mass pectrometric data. The structure of the substance found 
in the tablet corresponds to2C-B. 
Because more tablets from sample Bwere available, we de- 
cided to perform aparticular NMR experiment called HMBC 
which connects protons and carbons at long range (2j, 3j) 
and permits also an unequivocal determination f its struc- 
ture. Furthermore, we used the gsHMBC sequence with gra- 
dients, which is less time consuming than the usual 
experiments (COLOC, HMBC). The HMBC spectra (Figure 9) 
gave us, directly and without ambiguity, the structure of 2C- 
B only. 
In Figure 9, on the top and horizontally, is the hydrogen di- 
mension spectra nd, vertically on the left, the nC dimension 
spectra. Any "spot" or cross-peak inthe two dimension spectra 
shows a connection between hydrogen and carbon. There are 
two different types of crosspeaks: those which are doublet and 
those which are single. The C-H (L j) signals only appear as a 
doublet, and all the others (U, 3.i) are single crosspeaks. The Ar- 
CH2 group shows correlation with CHzNHz and with C~, Ci, and 
C2. Knowing the chemical shift of Cz, we can distinguish the 
two methoxy groups. 
In addition, ]3C-NMR and ]H-NMR spectra simulation 
matched the structure of 2C-B (results not shown), and LH- 
NMR spectra of 4-bromo-2,5-dimethoxyphenethylamine hy- 
drochloride were identical toour data. 
In conclusion, provided that he unknown compound is avail- 
able in a sufficient amount at a requested purity, gs-HMBC is 
the experiment of choice that gives, in a simple way, NMR data 
enabling full structure determination. However, FTIR and/or 
MS are still needed to emonstrate the presence of the bromine 
atom in 2C-B. 
+++o 9 2 .+o - + - 7+o "  +4+o 
Figure 8. UV spectra of the unknown, of the 2C-B standard and of caffeine obtained by HPLC-DAD. 
Quantitative results 
2C-B was quantitated in the tablets by HPLC-DAD and CE- 
DAD. Both methods howed linear responses 
over the concentration range tested and gave 
comparable r sults for both samples. The con- 
tent of 2C-B varied between 5 and 8 mg per 
tablet for sample A (4 tablets analyzed) and be- 
tween 3 and 5 mg per tablet for sample B (10
tablets analyzed). Because of th low number of 
2C-B tablets available and the relatively high 
amount of pure 2C-B needed to perform NMR 
studies, a full statistical analysis of the data 
could not be obtained. 
Conclusion 
4-Bromo-2,5-dimethoxyphenylethylamine 
was unequivocally identified in illicit tablets by 
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Figure 9. 2C-B spectra, gs-HMBC (600 MHz) in D20. The upper t ace corresponds to the ~ H-NMR 
spectrum and the trace on the left-side tothe 13C.NM R spectrum. X represents the signal of an im- 
purity (ethylene glycol) that did not interfere with our data. 
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